Swallow Prostaphane®, preferably with a glass of water, at mealtime.
One to three tablets are recommended per day (up to 6 in special cases), for a period of three to six months.
Renew regularly. Do not exceed the recommended daily dose without medical advice.
Prostaphane® is a dietary supplement intended for men above age 45, feeling the first signs of physiological aging of the prostate, such as frequent need to urinate, weak urine stream, difficulty urinating, or sometimes a feeling of incomplete bladder emptying.
Prostaphane® is made without added sugar. It is suitable for diabetics.
There is no known interaction with blood pressure medicine.
Prostaphane® does not have any contraindications.
However, you are advised to inform your doctor that you are taking Prostaphane®, just as you would if you were taking any other food supplement.
No cases of urine colour change by Prostaphane® have been recorded.
There is no known interaction with cholesterol-lowering drugs.
Use of Prostaphane® has no effect on uric acid levels.
Prostaphane® is a dietary supplement, produced in France, which complies with European standards. Each manufacturing stage meets specific specifications.
Tests and checks are conducted throughout the process to ensure product quality. Traceability is ensured from broccoli seed production to distribution of the boxes.
Prostaphane® is a dietary supplement marketed in France since 2012, available at pharmacies. Don’t hesitate to ask your pharmacist about Prostaphane®.
The natural sulforaphane contained in Prostaphane® tablets is sensitive to heat. Keeping Prostaphane® cool preserves the qualities of the active ingredient.
However, if necessary, Prostaphane® can be kept at room temperature one or two days.
There are no known interactions between Prostaphane® and anti-vitamin K drugs (AVK). Vitamin K dosage was carried out in the extract developed by Nutrinov, found in trace state. A 30-tablet box of Prostaphane® provides less than 1µg of vitamin K. Nevertheless it is important to continue INR monitoring.